Danaher Corporation
| Company type | Public |
|---|---|
| Industry | Healthcare industry |
| Founded |
|
| Founders | |
| Headquarters | Washington, D.C., US |
Area served | Worldwide |
Key people | Steven Rales (chairman of the board) Mitchell Rales (chairman of the executive committee) Rainer Blair (president and CEO) |
| Revenue | US$23.9 billion (2024) |
| US$4.86 billion (2024) | |
| US$3.90 billion (2024) | |
| Total assets | US$77.5 billion (2024) |
| Total equity | US$49.6 billion (2024) |
Number of employees | c. 63,000 (2024) |
| Divisions | List of divisions |
| Website | www |
| Footnotes / references | |
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.